Loading...
PT Kalbe Farma Tbk.
PTKFF•PNK
Healthcare
Drug Manufacturers - General
$0.07
$0.00(0.00%)
U.S. Market opens in 8h 20mPT Kalbe Farma Tbk. (PTKFF) AI-Powered Stock Analysis
See how PT Kalbe Farma Tbk. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerPT Kalbe Farma Tbk. (PTKFF) Stock Overall Grade
PT Kalbe Farma Tbk.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to PT Kalbe Farma Tbk.'s overall stock rating.
Forecast
C+Score
54/100Financial Growth
A+Score
90/100Fundamental Growth
C+Score
50/100Key Ratios
AScore
87/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100PT Kalbe Farma Tbk. (PTKFF) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 54/100 (C+), reflecting weak confidence in its potential. Financial Growth (90/100, A+) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (87/100, A) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each PT Kalbe Farma Tbk. stock grade, including financials, comparisons, and forecasts.